{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:30:18Z","timestamp":1790771418158,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.apsb.2021.03.028","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T04:53:54Z","timestamp":1616475234000},"page":"1607-1616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in\u00a0vitro and in\u00a0vivo DMPK assessment"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6148-5203","authenticated-orcid":false,"given":"Jiashu","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.03.028_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'Kovski","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.apsb.2021.03.028_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242128","article-title":"Reproductive number of coronavirus: a systematic review and meta-analysis based on global level evidence","volume":"15","author":"Billah","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2021.03.028_bib4","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3201\/eid2607.200282","article-title":"High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2","volume":"26","author":"Sanche","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.apsb.2021.03.028_bib5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S2213-2600(20)30514-2","article-title":"COVID-19 transmission-up in the air","volume":"8","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.apsb.2021.03.028_bib6","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 transmission and pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol"},{"key":"10.1016\/j.apsb.2021.03.028_bib7","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2008457","article-title":"Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility","volume":"382","author":"Arons","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.03.028_bib8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1473-3099(20)30114-6","article-title":"Asymptomatic cases in a family cluster with SARS-CoV-2 infection","volume":"20","author":"Pan","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.apsb.2021.03.028_bib9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJMc2001468","article-title":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","volume":"382","author":"Rothe","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.03.028_bib10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.abb3221","article-title":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)","volume":"368","author":"Li","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.apsb.2021.03.028_bib11","doi-asserted-by":"crossref","first-page":"m3862","DOI":"10.1136\/bmj.m3862","article-title":"Virology, transmission, and pathogenesis of SARS-CoV-2","volume":"371","author":"Cevik","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.apsb.2021.03.028_bib12","doi-asserted-by":"crossref","first-page":"2000607","DOI":"10.1183\/13993003.00607-2020","article-title":"Pathogenesis of COVID-19 from a cell biology perspective","volume":"55","author":"Mason","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.apsb.2021.03.028_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.apsb.2021.03.028_bib14","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.03.028_bib15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"Wolfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.03.028_bib16","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1038\/s41467-020-19057-5","article-title":"SARS-CoV-2 viral load is associated with increased disease severity and mortality","volume":"11","author":"Fajnzylber","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.03.028_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41564-020-00835-2","article-title":"Therapeutically administered ribonucleoside analogue MK-4482\/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets","volume":"6","author":"Cox","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.apsb.2021.03.028_bib18","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMp2032369","article-title":"FDA approval of Remdesivir\u2014a step in the right direction","volume":"383","author":"Rubin","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.03.028_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.03.028_bib20","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.bmcl.2012.02.105","article-title":"Synthesis and antiviral activity of a series of 1\u2032-substituted 4-aza-7,9-dideazaadenosine C-nucleosides","volume":"22","author":"Cho","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.03.028_bib21","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.jmedchem.6b01594","article-title":"Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses","volume":"60","author":"Siegel","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.03.028_bib22","doi-asserted-by":"crossref","first-page":"43395","DOI":"10.1038\/srep43395","article-title":"GS-5734 and its parent nucleoside analog inhibit filo-, pneumo-, and paramyxoviruses","volume":"7","author":"Lo","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.03.028_bib23","doi-asserted-by":"crossref","first-page":"107940","DOI":"10.1016\/j.celrep.2020.107940","article-title":"Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice","volume":"32","author":"Pruijssers","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2021.03.028_bib24","doi-asserted-by":"crossref","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2021.03.028_bib25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.03.028_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in\u00a0vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2021.03.028_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus susceptibility to the antiviral Remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.apsb.2021.03.028_bib29","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2021.03.028_bib30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/cts.12840","article-title":"Safety, tolerability, and pharmacokinetics of Remdesivir, an antiviral for treatment of COVID-19, in healthy subjects","volume":"13","author":"Humeniuk","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.apsb.2021.03.028_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1098612X19825701","article-title":"Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis","volume":"21","author":"Pedersen","year":"2019","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.apsb.2021.03.028_bib32","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/jvim.15780","article-title":"Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis","volume":"34","author":"Dickinson","year":"2020","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.apsb.2021.03.028_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","article-title":"The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies","volume":"219","author":"Murphy","year":"2018","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.apsb.2021.03.028_bib34","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1021\/acsmedchemlett.0c00316","article-title":"Advantages of the parent nucleoside GS-441524 over Remdesivir for COVID-19 treatment","volume":"11","author":"Yan","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.03.028_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-2423-5","article-title":"Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2","volume":"585","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.03.028_bib36","article-title":"Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice","author":"Hu","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.apsb.2021.03.028_bib37","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1128\/AAC.01814-20","article-title":"New perspectives on antimicrobial agents: remdesivir treatment for COVID-19","volume":"65","author":"Aleissa","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.03.028_bib38","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bcp.2005.09.002","article-title":"Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma","volume":"70","author":"Li","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2021.03.028_bib39","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1021\/ja035590q","article-title":"Aromatic hydroxylation by cytochrome P450: model calculations of mechanism and substituent effects","volume":"125","author":"Bathelt","year":"2003","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2021.03.028_bib40","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1021\/jm0613471","article-title":"Empirical regioselectivity models for human cytochromes P450 3A4, 2D6, and 2C9","volume":"50","author":"Sheridan","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.03.028_bib41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40262-015-0261-7","article-title":"Pharmacokinetic, pharmacodynamic, and drug-interaction profile of the hepatitis C Virus NS5B polymerase inhibitor Sofosbuvir","volume":"54","author":"Kirby","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.apsb.2021.03.028_bib42","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/jm100863x","article-title":"Discovery of a beta-d-2\u2032-deoxy-2\u2032-alpha-fluoro-2\u2032-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus","volume":"53","author":"Sofia","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.03.028_bib43","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1128\/AAC.49.5.1898-1906.2005","article-title":"Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue","volume":"49","author":"Lee","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.03.028_bib44","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/acs.jmedchem.7b00734","article-title":"The ProTide prodrug technology: from the concept to the clinic","volume":"61","author":"Mehellou","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.03.028_bib45","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/acsptsci.0c00076","article-title":"Metabolic efficacy of phosphate prodrugs and the Remdesivir paradigm","volume":"3","author":"Wiemer","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.apsb.2021.03.028_bib46","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19\u2014final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.03.028_bib47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cpdd.623","article-title":"Pharmacokinetics of tenofovir alafenamide, tenofovir, and emtricitabine following administration of coformulated emtricitabine\/tenofovir alafenamide in healthy Japanese subjects","volume":"8","author":"Yamada","year":"2019","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.apsb.2021.03.028_bib48","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1128\/AAC.01089-12","article-title":"Cobicistat boosts the intestinal absorption of transport substrates, including HIV protease inhibitors and GS-7340, in\u00a0vitro","volume":"56","author":"Lepist","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.03.028_bib49","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1038\/s41467-020-19055-7","article-title":"A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19","volume":"11","author":"Xie","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.03.028_bib50","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1007\/s00018-008-8123-1","article-title":"Adenosine kinase and ribokinase\u2014the RK family of proteins","volume":"65","author":"Park","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2021.03.028_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fnmol.2016.00099","article-title":"Dynamic regulation of the adenosine kinase gene during early postnatal brain development and maturation","volume":"9","author":"Kiese","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.apsb.2021.03.028_bib52","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.apsb.2021.03.028_bib53","unstructured":"Adenosine Kinase. Human protein atlas (version 20.1). Available from: http:\/\/www.proteinatlas.org."}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521001003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521001003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:50:04Z","timestamp":1761929404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521001003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2211383521001003"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.03.028","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in\u00a0vitro and in\u00a0vivo DMPK assessment","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}